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SUMMARY.-The presence of mucopolysaccharides (MPS) in leucocytes of
peripheral blood of 19 cancer patients, 13 patients with pulmonary tuberculosis
and 14 normal controls, was studied histochemically. MPS was revealed in
different proportions in polynuclears and mononuclears. According to the
staining technics, the MPS appear to be mainly carboxylated and contain
hyaluronic acid and chondroitinsulphate groups.
The quantitative analysis revealed that MPS appeared only in around 3%
ofleucocytes of normal controls, while in the cancer patients 56% of polynuclear
and 90% of mononuclears contained it. In the tuberculous patients, 90% of
polynuclears and 86% of the mononuclears revealed MPS. The differences
between the prevalence of leucocytes containing MPS in controls and in cancer
or tuberculous patients are highly significant.
The possibility that the difference in MPS content of leucocytes is related
with low inmunological activity is postulated.
THE mucopolysaccharide (MPS) content of cancerous tissues (Spicer et al.,
1962; Dobrogorski and Braunstein, 1963; Franks et al., 1964; Garcia-Buiiuel and
Monis, 1964; Lev, 1965; Hukill and Vidone, 1965, 1967; Esterly and Spicer, 1968)
and of pleural and peritoneal effusions of neoplastic origin (Castor and Naylor,
1967) is known to be above normal. The blood level ofthese substances (Shetlar
et al., 1950; Darcy, 1964; Bacchus et al., 1967) and their urinary excretion (Rich
and Laird, 1959) are also abnormally high in cancer patients, but the significance
of these changes has not yet been clarified. Attempts have been made to establish
a relationship between the MPS envelope of cancerous cells and their capacity to
produce metastases (Gasic and Gasic, 1962), as well as with their resistance to
antineoplastic immunological action (Sanford, 1967; Currie, 1967).
MPS have been found in polynuclear leucocytes of laboratory animals such as
guinea-pigs (Bazin and Delaunay, 1963) and rabbits (Bedorko and Stephen, 1965;
Horn and Spicer, 1964). Their presence in man has been described by Kerby,
1955, and subsequently Clausen and Anderson (1963) found them in leucocytes of
normal persons and neoplastic patients. We are not aware of studies demonstra-
ting quantitative differences between leucocyte MPS in normal and cancerous
subjects, or ofinvestigations revealing MPS in the lymphocytes ofcancer patients.
In a previous paper (Riesco, 1970) we have reported on a positive and statis-
tically significant correlation (P < 0.0005) between the number of lymphocytes
per ml. of peripheral blood and the proportion of cancer patients treated with
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conventional methods who survived for 5 years. A negative correlation was also
found (statistically significant; P < 0.005) between the number of neutrophils
per ml. of peripheral blood and the same rate of survival. Since these correla-
tions could have some connection with anticancerous immunological processes,
and some authors have attributed to MPS an inhibitory action on the immune
processes against cancer (Currie, 1967; Sanford, 1967), and to neutrophils the
function of transporting MPS (Bazin and Delaunay, 1963), we were interested in
studying histochemically the presence of MPS in lymphocytes and polynuclears
of cancer patients and normal individuals. In order to determine the specificity of
these variations, a similar study was undertaken in patients with pulmonary
tuberculosis, a chronic disease in whose development also immune processes play
a fundamentalrole.
MATERIAL AND METHODS
The group investigated in this study was composed of 46 subjects distributed
inthe 3 following groups:
Group A.-Composed of 19 cancer patients, 7 men and 12 women, whose age
ranged between 13 and 78 years. During the year 1969 they were treated at the
" Caupolican Pardo Correa Institute " (ex Radium Institute) of Santiago, Chile,
(National Health Service). In all cases the diagnoses had been established histo-
logically (Table I).
TABLE I.-Clinical and Anatopathological Diagnosis of the 19 Cancer Patients of
Group A
No. of
Diagnosis cases
Cervix uteri carcinoma . . . 5
Ovary adenocarcinoma . . . . 3
Mammary adenocarcinoma . . 2
Endometrial adenocarcinoma 1
Abdominal adenocarcinoma of undetermined origin 1
Cutaneous carcinoma ofthe cheek . 1
Thoracic melanocarcinoma . . . 1
Rectal adenocarcinoma . . . 1
Hodgkin's disease . . 1
Testicular seminoma . . . 1
Gum carcinoma . . . . 1
Laryngeal carcinoma . . . . 1
Total 19
Group B.-Composed of 13 pulmonary tuberculosis patients (11 men and
2 women, 26 to 60 years old). They were patients in the Hospital San Jose of
Santiago, Chile (National Health Service), during 1969. All had radiographic
proofoftheir pulmonary lesions and positive Koch bacillus in sputum.
Group C.-(Control group). Composed of 14 normal subjects (10 men and
4 women, 19 to 46 years old). They were voluntary blood donors of the Blood
Bank ofthe J. J. Aguirre Hospital of Santiago (University ofChile).
General Methods
In each subject a sample of blood was obtained under fasting condition by
venous puncture. The blood was immediately spread without previous treatment
on 6 to 8 haematological slides.
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In 15 ofthe 19 patients of group A (Table I), the sample was taken before the
beginning of the cancer treatment. In 2 of them (Hodgkin's disease and cervix
uteri carcinoma) the sample was taken half way through radiotherapy treatment.
In 2 other patients (ovary adenocarcinoma and cutaneous carcinoma ofthe cheek),
the sample was taken 2 days after the treatment was finished (5 mg. of metho-
trexate a day for 10 days, and surgical extirpation, respectively).
Qualitative Method
The main interest as far as the qualitative aspect was concerned lay in deter-
mining whether the mononuclear and polynuclear leucocytes had acid or neutral
MPS. Among acid MPS, interest was centered on whether sulphated or carboxylic
MPS were prevalent, and also whether hyaluronic acid or chondroitinsulphate
groups were present. Forthispurpose different histochemicaltechniques normally
used to recognize MPS in tissue sections were employed, with the necessary
adaptations forblood samples.
The majority of these techniques failed for our purpose, either because no
leucocytic structure was stained, or because total haemolysis or leucolysis was
produced; this last occurred particularly with techniques using a very low pH.
Only 3 ofthem were acceptable for our purposes. Two were useful only for quali-
tative diagnosis, and the other one for both qualitative and quantitative study
ofleucocytic MPS.
Techniques employedfor qualitative method
1. Fixing.-The slides with blood samples were fixed by drying at room
temperature for 3 days.
2. Staining
(a) Metachromasia, pH 6-4 (Kramer andWindrum, 1965).
(b) ModifiedPAS (Cubillos, 1969).
(c) Alcian Blue pH 2-5 (Mowry, 1956).
Control techniques
(a) Methylation (Lillie, 1958).
(b) Diastase digestion (Spicer, 1965).
(c) Hyaluronidase digestion (Spicer, 1965).
Quantitative Method
For the quantitative determination of leucocyte MPS a histochemical tech-
nique specific for leucocytes and giving distinct staining was needed. The only
technique fulfilling these conditions was Alcian Blue at pH 2-5 according to
Mowry (1956). All the quantitative studies here reported were performed with
thistechnique.
Using this method the cytoplasmic MPS ofthe neutrophil is stained distinctly
and uniformly light blue. In mononuclears (lymphocytes), MPS appears in the
cell periphery as a thin film ofvarying width. Because ofits thinness, it is difficult
to be sure whether it occurs in the cytoplasm itselfor is outside the cell. In most
cases MPS occupies the whole cellular perimeter, but sometimes it takes a half
moon shape.
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The MPS of the different mononuclears of the same slide appear stained with
unequal intensity. Some were well coloured, some very lightly stained and others
not stained at all. The proportion of unstained, lightly stained or well stained
leucocytes appearing in the same slide, was different from subject to subject, and
we thought that the clinical group had some influence in these differences. We
decided therefore to establish a system to measure the proportion of leucocytes
with each colour intensity. A standard was prepared with the same colour and
intensity as those found in the different stained leucocytes. According to the
degree of colour intensity, the staining was classified as: none (0), light (1),
moderate (2) and intense (3). The first 40 polynuclears (neutrophil) and mono-
nuclears (lymphocytes) in each slide were classified.
RESULTS
Qualitative results
Since polynuclears (neutrophils) as well as mononuclears (lymphocytes) were
stained with MPS specific dyes, it can be stated that these blood cells contain
mucopolysaccharides. Previous methylation always prevented the leucocyte
staining with Alcian Blue at pH 2-5, confirming that this staining was specific
for acid MPS. On the other hand, as the staining was performed at pH 2-5 we
can deduce that carboxylic groups are prevalent, but the presence of sulphuric
groups cannot be discarded. Previous digestion with diastase prevented in all
the cases the leucocytes staining with PAS, showing that this was due to glycogen
and not to neutral MPS. Previous digestion with hyaluronidase prevented the
Alcian Blue staining at pH 2-5, indicating that hyaluronic acid or chondroitin-
sulphate groups were mainly responsible for this colouring.
Thus we have evidence that the staining observed in neutrophils and lympho-
cytes was due to MPS. This was found in the 3 clinical groups. The chemical
characterization showed that MPS found in leucocytes is exclusively acid, pre-
dominantly carboxylated, and contained chondroitinsulphate groups and hyal-
uronic acid. Moreover the absence of neutral MPS was proved.
No qualitative difference between leucocytic MPS in cancer or tuberculosis
patients and normal individuals was observed.
Quantitative results
The results in Table II show that in the peripheral blood of normal subjects,
neutrophils with noticeable quantities of cytoplasmic MPS (intensity 2 and 3)
were very scarce (4%). In contradistinction, only about 36% of the neutrophils
of peripheral blood of cancer and tuberculosis patients had no or small amounts
ofMPS (intensity 0 and 1). Regarding mononuclears (lymphocytes) ofperipheral
blood, the cells without MPS or with very small amounts represented 97% in
normal subjects (group C), 53% in the cancer patients (group A) and 15% in the
tuberculosis (Group B).
Table III shows the x2 value with one degree of freedom considering on one
hand the intensity 0 and on the other the intensities 1, 2 and 3, comparing cancer
or tuberculosis patients with normal subjects. These values mean that the
differences are very clear, allowing for the rejection of the null hypothesis with
almost absolute certainty.
Studying the possible influence that the cancer treatment had on the differ-
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TABLE II.-Distribution of Mucopolysaccharide Content (Intensity of Staining) of
Leucocytes in the Groups Studied
Leucocytes
Cancer* Tuberculosis Control*
Type of Intensity of , , - >
leucocytes staining N % N % N %
Mononuclear 0 . 168 44-2 . 26 10 0 . 259 92 6
1 . 35 92. 14 53. 12 4-6
2 . 93 24-5 45 17-3 8 2-8
3 . 84 22-1 175 674. 0 00
Total . - . 380 100 0 . 260 100 0 . 280 100 0
Polynuclear . 0 . 76 10 0 . 74 14-2 . 296 52-9
1 . 201 264 . 113 21-7 . 245 43-7
2 .304 40-1 .204 393. 19 3-4
3 179 23-5 129 24-8 . 0 0 0
Total . . 760 100 0 . 520 100-0 . 560 100 0
* 19 patients with cancer, 13 with tuberculosis and 14 control subjects.
TABLE III.-Statistical Analysis of the Data Shown in Table II by x2 Test with
One Degree ofFreedom*
Mononuclears Polynuclears
x2 x2
Cancer v. controls . 176 292
TBCv. controls . 368 178
* Considering cases with staining degree 1, 2 and 3 on one side and 0 on the other.
ences found in leucocyte MPS, the 4 cases in which the blood sample was taken
during and after the treatment were eliminated from the statistical study (see
General Method and Table III). Despite that, in the remaining group in which
the sample was taken before the treatment, the statistical result persisted in a
high degree (X2 152 in mononuclears; x2 185 in polynuclears). This would
indicate that the differences found are independent ofthe treatment.
The present results show clearly that the neutrophils as well as the lympho-
cytes of peripheral blood in normal persons are almost completely free of histo-
chemically detectable MPS (96-97%). On the other hand, in cancer and pulmon-
ary tuberculosis patients the proportion of peripheral leucocytes free of MPS is
verymuchlower.
In fact, the proportion of peripheral blood neutrophils and lymphocytes
containing MPS in cancer patients is 15 times higher than in normal controls.
In pulmonary tuberculosis patients, the number of neutrophils containing MPS
is also 15 times higher than normal, while that oflymphocyteswithMPSis 27times
higherthannormal.
DISCUSSION
The qualitative histochemical finding of MPS in human neutrophils agrees
with previous results obtained through chemical methods in man and laboratory
results obtained through chemical methods in man and laboratory animals
(Bazin and Delaunay, 1963; Clausen and Anderson, 1963; Bedorko and Stephen,
1965; Horn and Spicer, 1964; Kerby, 1955).
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Furthermore our results reveal in some lymphocytes of peripheral blood a
thin film of MPS which appears to be qualitatively similar to that observed in
some neutrophils.
The quantitative results of this investigation establish the point that there is
a much higher number of mononuclear and polynuclear leucocytes containing
MPS in cancer and pulmonary tuberculosis patients than in normal persons, and
this is statistically significant. We have not found references in literature about
these quantitative differences in leucocyte MPS. These results raise several
questions. One of them is whether the increase of MPS in cancerous tissues, in
pleural and peritoneal effusions, in blood serum and urinary elimination in cancer
patients is produced by the greater amount ofleucocyte MPS or ifthat is its cause.
It is not known whether leucocyte MPS is produced by leucocytes themselves or
if they merely assimilate it from other sources. It also remains unknown whether
this abnormal increase of leucocyte MPS observed in cancer and pulmonary
tuberculosis patients is due to some cause acting on peripheral leucocytes, or
acting on haematopoietic tissues. Moreover it is not known whether this
abnormality is a causal factor in the development ofthe illness, or rather an effect
ofit.
The results here reported have some relation with those we have recently
published (Riesco, 1970) about the 5 years' survival of cancer patients, which
appeared to be higher in those patients having a normal or raised number of
lymphocytes in circulating blood and lower in those having abnormally high
number of polynuclears. Both results open a new problem regarding the even-
tual importance ofthese two types ofleucocytes in anticancerous immunity.
We are indebted to Professor Jorge Mardones for his help in the preparation
of the manuscript, and to Miss Adriana Martinez and Miss Aida Aranda for
technical help.
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